home / stock / cort / cort quote
Last: | $33.34 |
---|---|
Change Percent: | -1.79% |
Open: | $32.93 |
Close: | $33.34 |
High: | $33.685 |
Low: | $32.56 |
Volume: | 941,859 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$33.34 | $32.93 | $33.34 | $33.685 | $32.56 | 941,859 | 07-16-2024 |
$32.35 | $31.89 | $32.35 | $32.48 | $31.4598 | 644,877 | 07-15-2024 |
$31.5 | $31.49 | $31.5 | $32.13 | $31.18 | 714,445 | 07-12-2024 |
$31.17 | $31.33 | $31.17 | $31.6 | $30.77 | 662,917 | 07-11-2024 |
$30.62 | $30.25 | $30.62 | $30.67 | $30.04 | 480,847 | 07-10-2024 |
$29.9 | $29.64 | $29.9 | $30.25 | $29.42 | 585,218 | 07-09-2024 |
$29.51 | $30.37 | $29.51 | $30.67 | $29.45 | 873,493 | 07-08-2024 |
$30.08 | $30.34 | $30.08 | $31 | $30 | 1,015,605 | 07-05-2024 |
$30.5 | $31.53 | $30.5 | $31.58 | $30.15 | 559,717 | 07-04-2024 |
$30.5 | $31.53 | $30.5 | $31.58 | $30.15 | 559,717 | 07-03-2024 |
$31.56 | $32.67 | $31.56 | $32.93 | $31.52 | 977,714 | 07-02-2024 |
$32.67 | $32.49 | $32.67 | $33.69 | $32.45 | 1,210,124 | 07-01-2024 |
$32.49 | $32.3 | $32.49 | $32.81 | $31.92 | 1,550,631 | 06-28-2024 |
$32.06 | $31.62 | $32.06 | $32.1 | $31.24 | 791,388 | 06-27-2024 |
$31.6 | $30.22 | $31.6 | $31.6 | $29.86 | 844,299 | 06-26-2024 |
$30.39 | $30.93 | $30.39 | $31.46 | $30.39 | 738,565 | 06-25-2024 |
$30.59 | $30.16 | $30.59 | $31.23 | $30 | 774,486 | 06-24-2024 |
$30.04 | $29.18 | $30.04 | $30.34 | $29.18 | 1,841,049 | 06-21-2024 |
$29.4 | $28.34 | $29.4 | $29.46 | $28.1 | 1,004,838 | 06-20-2024 |
$28.15 | $28.62 | $28.15 | $28.93 | $28.09 | 1,002,686 | 06-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
Corcept Therapeutics Incorporated Company Name:
CORT Stock Symbol:
NASDAQ Market:
Corcept Therapeutics Incorporated Website:
Results from the CATALYST clinical trial were presented at the American Diabetes Association’s 84 th Scientific Sessions at a featured plenary session titled: “Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes” With 1,055 patients enro...
2024-06-12 10:00:07 ET Edward Nash from Canaccord Genuity issued a price target of $38.00 for CORT on 2024-06-12 07:45:00. The adjusted price target was set to $38.00. At the time of the announcement, CORT was trading at $32.79. The overall price target consensus is at $...